targeted therapy

Johnson & Johnson is headquartered in New Brunswick.
Jun 9, 2026

J&J to buy Firefly Bio for $1B to boost cancer pipeline

Johnson & Johnson will acquire Firefly Bio for $1 billion, adding cancer-targeting technology to expand its oncology pipeline.